In detail, one study evaluated gene expression profiles of AD lesions in different stages (acute vs. chronic) and found that acute disease was predominantly associated with significant increases in gene expression levels of major Th22- and Th2-cytokines, and smaller increases in IL-17 [25]. Here, IL17A is linked to Alzheimer disease.